CPT and ICD-9 Codes

Product	Potentially Relevant CPT Codes1	Descriptor	ICD-9-CM Diagnosis Codes2
BNP Test			ICD-9 Codes
BNP	83880	Natriuretic peptide
Cardiac Panel			ICD-9 Codes
CK-MB	82553	Creatine, MB fraction
Myoglobin	83874	Assay of myoglobin
Troponin-I	84484	Assay of troponin, quant
Profiler Shortness of Breath Panel			ICD-9 Codes
BNP	83880	Natriuretic peptide
CK-MB	82553	Creatine, MB fraction
D-dimer	85379	Fibrin degradation, quant
Myoglobin	83874	Assay of myoglobin
Troponin-I	84484	Assay of troponin, quant
D-dimer Test			ICD-9 Codes
D-Dimer	85379	Fibrin degradation, quant
Parasite Panel			ICD-9 Codes
Entamoeba	87336	Entamoeb hist dispr, ag, eia
Giardia	87329	Giardia ag, eia
Crypto	87328	Cryptosporidium ag, eia
Drugs of Abuse			ICD-9 Codes
TOX Drug Screen	G0430	Drug Screen, each procedure
TOX Drug Screen	G0431	Drug Screen, each drug class
Drugs of Abuse Panel	G0430	Drug Screen, each procedure

¹CPT is a copyright and registered trademark of the American Medical Association (AMA). Please consult with current CPT Manual for full descriptors and instructions regarding the use of these codes.

²For illustrative purposes only. Providers should follow coding conventions for diagnostic tests as well as payer instructions when selecting appropriate ICD-9-CM diagnosis codes. See Medicare Claims Processing Manual (Pub 100-4), Chapter 23, Section 10.1.

Disclaimer: The information provided on this website is current as of February 2005 and was obtained from third-party sources and is subject to change without notice as a result of changes in reimbursement laws, regulations, rules, policies, and payment amounts. All content on this website is informational only, general in nature, and does not cover all situations or all payers’ rules and policies. This content is not intended to instruct hospitals and/or physicians on how to use or bill for healthcare procedures, including new technologies outside of Medicare national guidelines. A determination of medical necessity is a prerequisite that Biosite Incorporated assumes will have been made prior to assigning codes or requesting payments.

Under Federal and State law, it is the individual provider's responsibility to determine appropriate coding, charges and claims for a particular service. Policies regarding appropriate coding and payment levels can vary greatly from payer to payer and change over time. Biosite recommends that providers contact their own regional payers to determine appropriate coding and charge or payment levels.

If you are a provider participating in a clinical trial, we recommend you contact your payers, including Medicare/Medicaid and private insurers, to verify correct coverage and reimbursement policies for investigational devices.

This website information represents no promise or guarantee by Biosite Incorporated concerning coverage, coding, billing, and payment levels. Biosite Incorporated specifically disclaims liability or responsibility for the results or consequences of any actions taken in reliance on information on this website.